| Cash and cash equivalents |
114.55M |
| Restricted cash |
5.7M |
| Investment securities, trading |
3.75M |
| Investment securities available-for-sale, pledged as collateral, at fair value |
82.1M |
| Investment securities available-for-sale, at fair value |
| Investment securities held-to-maturity, pledged as collateral |
| Property available-for-sale |
| Investments in real estate |
| Loans, pledged as collateral and net of allowances of $29.7 million and $34.2 million |
1.41B |
| Loans held for sale |
| Lease receivables, pledged as collateral, net of allowances of $0 and $70,000 and net of unearned income |
| Loans receivable-related party |
| Investments in unconsolidated entities |
88.15M |
| Dividend reinvestment plan proceeds receivable |
| Interest receivable |
6.62M |
| Deferred tax asset |
5.57M |
| Intangible assets |
| Other assets |
12.52M |
| Total assets |
2.16B |
| Borrowings |
| Distribution payable |
17.02M |
| Accrued interest expense |
4.91M |
| Derivatives, at fair value |
2.16M |
| Deferred tax liability |
| Accounts payable and other liabilities |
12.93M |
| Total liabilities |
1.44B |
| Preferred stock, par value $0.001: 100,000,000 shares authorized; no shares issued and outstanding |
1K |
| Common stock, par value $0.001: 500,000,000 shares authorized; 74,230,500 and 58,183,425 shares issues and outstanding (including 1,192,388 and 534,957 unvested restricted shares) |
31K |
| Additional paid-in capital |
1.22B |
| Accumulated other comprehensive loss |
6.91M |
| Distributions in excess of earnings |
-506.11M |
| Total stockholders' equity |
719.75M |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
2.16B |
